ArticlePreventive medicine reports2026
Medicine quality in Somalia: Strengthening the pharmaceutical supply chain to protect patients.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To highlight medicine quality as a patient-safety and public-health priority in Somalia and propose practical priorities for strengthening the pharmaceutical supply chain. Methods: This commentary draws on published literature and recent policy and regulatory developments concerning medicine quality, pharmaceutical governance, and supply-chain systems in Somalia and related settings. Results: Key vulnerabilities include limited regulatory and laboratory capacity, weaknesses in post-market surveillance, storage and distribution challenges, and insufficient integration of pharmacy professionals into medicine-quality monitoring. Recent legislative progress provides an opportunity to strengthen national regulation, but implementation, enforcement, financing, and technical capacity remain important. Conclusions: Somalia should strengthen risk-based regulatory inspection, practical post-market surveillance, supply-chain quality standards, product traceability and recall systems, and the formal role of pharmacists in medicine-quality monitoring and pharmacovigilance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.